Rachel A.

Rachel A. has an extensive work history, with their most recent role being the VP of Clinical Development at Leap Therapeutics since September 2022. Prior to that, they served as the VP of Oncology Development at Gossamer Bio from September 2021 to January 2022. Rachel also held various positions at Merck, starting as a Senior Medical Director from May 2016 to December 2020, and then transitioning to an Executive Director role from December 2020 to September 2021. Rachel worked as a Medical Director at Bristol Myers Squibb from June 2014 to May 2016. Additionally, Rachel had academic roles, including being an Associate Professor at The Warren Alpert Medical School of Brown University from January 2007 to June 2014, and an Assistant Professor at The Ohio State University Wexner Medical Center from January 1999 to June 2007.

Rachel A. has a Bachelor of Arts degree in Biochemistry from Brandeis University. Rachel also holds a Doctor of Medicine (MD) degree from Washington University in St. Louis.